exacerb
asthma
chronic
obstruct
pulmonari
diseas
major
burden
healthcar
system
contribut
significantli
mortal
morbid
associ
diseas
upper
respiratori
viral
infect
associ
major
diseas
exacerb
past
year
seen
advanc
mechan
viral
infect
induc
proinflammatori
chemokin
product
understand
host
antivir
antiinflammatori
defenc
pathway
might
regul
respons
infect
comprehens
understand
molecular
basi
process
could
elucid
new
therapeut
approach
reduc
devast
impact
exacerb
qualiti
life
healthcar
cost
exacerb
asthma
chronic
obstruct
pulmonari
diseas
copd
defin
worsen
patient
condit
beyond
daytoday
variabl
associ
diseas
suffici
enough
requir
chang
manag
seek
emerg
medic
intervent
exacerb
asthma
copd
repres
major
financi
burden
healthcar
system
result
cost
associ
hospit
increas
medic
usag
day
lost
work
school
case
asthma
exacerb
respons
total
healthcar
cost
death
american
year
similarli
case
copd
exacerb
account
healthcar
cost
well
substanti
caus
hospit
importantli
recurr
exacerb
copd
result
loss
lung
function
thu
hasten
progress
current
fatal
diseas
current
articl
discuss
evid
common
respiratori
virus
major
trigger
factor
exacerb
asthma
copd
also
review
current
state
knowledg
mechan
virus
might
trigger
diseas
exacerb
well
factor
could
regul
suscept
viral
exacerb
final
consid
statu
current
therapi
treatment
viral
exacerb
asthma
copd
discuss
potenti
novel
approach
treatment
associ
upper
respiratori
viral
infect
uri
exacerb
asthma
recogn
decad
develop
rtpcr
method
improv
detect
virus
extent
associ
becam
clear
inde
uri
princip
risk
factor
associ
asthma
exacerb
associ
mani
asthma
exacerb
children
adolesc
approxim
exacerb
adult
clear
tempor
relationship
uri
asthma
exacerb
children
peak
hospit
occur
septemb
shortli
return
school
peak
time
year
human
rhinoviru
hrv
infect
consist
hrv
associ
approxim
viraltrigg
exacerb
viral
type
associ
asthma
exacerb
includ
influenza
coronavirus
parainfluenza
respiratori
syncyti
viru
epidemiolog
evid
suggest
virus
may
also
interact
causal
factor
link
asthma
exacerb
allergen
pollut
studi
interact
experiment
allergen
exposur
experiment
viru
infect
howev
gener
mix
result
murin
model
influenza
infect
aid
allergen
sensitis
enhanc
airway
inflamm
human
howev
chronic
lowdos
allergen
provoc
alter
subsequ
lower
airway
respons
hrv
infect
wherea
upper
airway
acut
allergen
challeng
delay
onset
shorten
durat
common
cold
copd
predict
becom
third
common
caus
death
worldwid
fifth
lead
caus
disabl
exacerb
copd
occur
commonli
patient
advanc
gold
ii
iii
stage
gold
stand
global
initi
chronic
obstruct
lung
diseas
rank
diseas
four
stage
risk
stage
mild
copd
stage
ii
moder
copd
stage
iii
sever
copd
recent
evid
demonstr
uri
major
trigger
recent
studi
sever
exacerb
patient
copd
associ
viral
andor
bacteri
infect
viral
infect
account
exacerb
interestingli
viralassoci
exacerb
copd
frequent
sever
longer
recoveri
time
nonvir
origin
moreov
exacerb
associ
viralbacteri
coinfect
also
result
longer
hospitalis
wors
function
impair
patient
patient
copd
exacerb
requir
mechan
ventil
viral
pathogen
detect
case
gener
viral
infect
respons
approxim
exacerb
copd
hrv
domin
pathogen
consist
exacerb
frequenc
associ
increas
frequenc
acquir
common
cold
moreov
experiment
hrv
infect
patient
gold
stage
ii
copd
result
symptom
lung
function
chang
repres
acut
diseas
exacerb
specif
mechan
virus
invok
exacerb
asthma
copd
remain
unclear
grow
evid
howev
suggest
direct
infect
lower
respiratori
tract
lead
robust
host
inflammatori
respons
increas
bronchial
hyperrespons
hrv
major
viral
type
associ
exacerb
focu
viru
prototyp
mechan
virus
exert
effect
hrv
infect
upper
lower
respiratori
tract
princip
site
infect
airway
epitheli
cell
although
report
strain
hrv
caus
epitheli
cell
death
cultur
grown
low
densiti
major
studi
found
overt
cytotox
either
vitro
vivo
epitheli
cell
clearli
major
site
hrv
infect
sustain
prolong
replic
although
hrv
bind
enter
varieti
cell
type
vitro
includ
fibroblast
monocyt
macrophag
contribut
individu
cell
type
pathogenesi
vivo
still
unclear
hrv
infect
cultur
human
airway
epitheli
cell
result
product
sever
proinflammatori
cytokin
chemokin
includ
interleukin
il
interferon
ifn
induc
protein
kda
regul
activ
normal
tcell
express
rant
granulocyt
macrophagecoloni
stimul
factor
eotaxin
profil
mediat
could
enhanc
airway
inflamm
via
recruit
retent
wide
rang
inflammatori
cell
figur
contribut
pathogenesi
exacerb
moreov
chemokin
also
detect
airway
secret
viral
infect
despit
potenti
epitheli
chemokin
recruit
multipl
cell
type
airway
experiment
hrv
infect
viral
exacerb
asthma
copd
dominantli
associ
select
recruit
neutrophil
lymphocyt
impli
mechan
must
exist
limit
cell
type
recruit
mechan
well
understood
recent
report
increas
gene
express
observ
viral
exacerb
asthma
suggest
immunoregulatori
effect
includ
suppress
eosinophil
influx
viral
infect
might
also
contribut
diseas
exacerb
enhanc
mucu
product
hrv
infect
epitheli
cell
shown
result
increas
mrna
express
importantli
concentr
total
mucin
also
increas
supernat
lysat
epitheli
cell
although
viral
infect
modul
epitheli
cell
function
viralinduc
signal
mechan
involv
begin
elucid
induct
chemokin
occur
earli
hrv
bind
requir
viral
replic
instead
depend
upon
activ
phosphatidylinositol
mitogenactiv
protein
kinas
pathway
given
intercellular
adhes
receptor
major
hrv
serotyp
inher
kinas
activ
recognit
motif
receptorassoci
kinas
unclear
viral
bind
initi
signal
cascad
howev
recent
shown
hrv
bind
lead
associ
spleen
tyrosin
kinas
syk
associ
mediat
via
cytoskelet
linker
protein
ezrin
bind
syk
format
complex
lead
activ
syk
subsequ
downstream
activ
mitogenactiv
protein
kinas
pathway
increas
express
thu
syk
import
signal
compon
earli
viru
respons
contrast
rapid
gener
respons
viral
infect
gener
rant
occur
sever
hour
viral
exposur
absolut
depend
upon
viral
replic
led
intens
investig
role
viral
replic
product
particularli
doublestrand
rna
dsrna
cell
respons
known
dsrna
mimic
sever
respons
viral
infect
trigger
host
antivir
respons
initi
dsrna
thought
recogn
exclus
tolllik
receptor
tlr
genet
delet
alter
viral
pathogenesi
host
adapt
antivir
respons
sever
virus
appar
conundrum
resolv
demonstr
two
intracellular
rna
helicas
retino
acid
induc
gene
rigi
melanomadifferentiationassoci
gene
also
bind
dsrna
helicas
domain
protein
bind
dsrna
caspas
activ
recruit
domain
card
permit
bind
downstream
adaptor
protein
downstream
mitochondrialassoci
protein
identifi
independ
four
group
known
name
cardif
card
adapt
induc
interferonb
mav
mitochondri
antivir
signal
interferonb
promot
visa
virusinduc
signal
adapt
cardif
bind
sever
protein
induc
classic
nuclear
factorkb
nfkb
pathway
activ
ikketankbind
kinas
activ
interferon
respons
factor
pathway
also
activ
dsrna
bind
figur
controversi
exist
regard
rel
role
rigi
viral
recognit
suggest
differ
viral
type
may
preferenti
util
one
three
recognit
protein
complic
pictur
rigi
also
recogn
singlestrand
rna
ssrna
contain
phosphat
inde
report
influenza
gener
dsrna
rather
activ
rigi
via
bind
genom
viral
ssrna
bear
phosphat
studi
need
clarifi
preferenti
util
differ
intracellular
recognit
molecul
differ
viral
type
determin
also
vari
cell
type
mechan
virusassoci
exacerb
asthma
copd
viral
infect
epithelium
result
upregul
proinflammatori
mediat
also
releas
recruit
inflammatori
cell
neutrophil
monocyt
differenti
macrophag
lymphocyt
eosinophil
inflammatori
cell
also
releas
inflammatori
mediat
chemokin
cytokin
matrix
metalloproteinas
mmp
reactiv
oxygen
speci
ro
perpetu
inflammatori
respons
culmin
exacerb
determin
suscept
given
individu
experi
diseas
exacerb
upon
viral
infect
clear
multipl
factor
probabl
involv
subject
whose
underli
diseas
well
control
less
like
experi
acut
viralmedi
exacerb
similarli
preexist
specif
immun
given
pathogen
reduc
likelihood
pathogen
trigger
exacerb
epitheli
contribut
host
innat
antivir
immun
might
also
play
role
recent
report
suggest
bronchial
epitheli
cell
asthmat
subject
show
impair
product
ifnb
type
ifn
play
role
increas
suscept
asthmat
subject
lower
airway
diseas
addit
studi
need
confirm
data
put
defect
context
specif
asthmat
subject
experi
exacerb
moreov
although
type
type
ifn
contribut
host
defenc
mainli
via
induct
numer
ifnstimul
gene
isg
collect
limit
viru
replic
spread
preced
sever
virus
includ
hrv
induc
isg
independ
ifn
induct
overview
intracellular
signal
pathway
stimul
rhinoviru
hrv
bind
surfac
epitheli
cell
viru
becom
internalis
replic
produc
dsrna
dsrna
bind
activ
adaptor
induc
interferon
b
trif
subsequ
either
interferon
regulatori
factor
irf
nfkb
dsrna
also
bind
either
rigi
result
activ
irfor
nfkbmediat
pathway
thought
activ
irf
nfkb
stimul
product
antivir
respons
fadd
fasassoci
death
domain
protein
ikk
inhibitor
nfkb
kinas
famili
interferonb
promot
stimul
mav
mitochondri
antivir
signal
kinas
receptor
interact
tbk
tankbind
kinas
traf
tumor
necrosi
factor
receptorassoci
factor
visa
virusinduc
signal
adaptor
nitric
oxid
also
appear
import
compon
host
antivir
respons
exert
direct
antivir
activ
sever
virus
associ
exacerb
asthma
copd
also
inhibit
viralinduc
gener
sever
cytokineschemokin
epitheli
cell
viral
infect
epitheli
cell
increas
express
induc
synthas
ino
vivo
hrv
infect
epitheli
ino
induct
correl
level
exhal
moreov
subject
highest
level
exhal
clear
viru
rapidli
fewer
symptom
exhal
lower
level
corticosteriod
crucial
treatment
asthma
use
alon
combin
longact
bagonist
leukotrien
receptor
antagonist
known
improv
asthma
control
therebi
reduc
number
exacerb
acut
asthma
exacerb
tend
treat
oxygen
inhal
shortact
agonist
intraven
oral
corticosteroid
although
use
oral
corticosteroid
earli
exacerb
reduc
subsequ
relaps
studi
look
specif
exacerb
known
viral
etiolog
corticosteroid
ineffect
treatment
hrvinduc
cold
current
evid
would
suggest
limit
efficaci
viralinduc
excerb
asthma
asthmat
promin
sputum
neutrophilia
perhap
indic
viral
etiolog
poorli
respons
inhal
corticosteroid
inhal
corticoisteroid
significantli
reduc
lower
airway
inflamm
induc
hrv
infect
asthmat
subject
moreov
administr
prednisolon
children
hospit
viralinduc
episod
wheezi
bronchiol
reduc
durat
hospit
stay
combin
therapi
inhal
anticholinerg
agent
shortact
agonist
report
effect
exacerb
school
children
furthermor
leukotrien
receptor
antagonist
decreas
asthma
exacerb
patient
intermitt
asthma
nedocromil
sodium
inhal
corticosteroid
might
also
limit
benefit
asthma
exacerb
children
must
note
howev
studi
discrimin
exacerb
viral
nonvir
origin
although
conflict
evid
whether
inhal
corticosteroid
reduc
exacerb
copd
oral
corticosteroid
appear
hasten
recoveri
certain
exacerb
combin
therapi
corticosteroid
longact
badrenoceptor
agonist
shown
reduc
number
exacerb
patient
copd
presum
improv
baselin
control
howev
studi
specif
examin
effect
corticosteroid
alon
combin
longact
badrenoceptor
agonist
copd
exacerb
known
viral
etiolog
similarli
although
antibiot
therapi
wide
use
exacerb
copd
util
viral
trigger
exacerb
question
antivir
approach
appear
logic
altern
treatment
viral
exacerb
asthma
copd
influenza
vaccin
clearli
effect
prevent
exacerb
trigger
viru
vaccin
approach
success
respiratori
syncyti
viru
howev
feasibl
hrv
given
larg
number
viral
serotyp
antivir
agent
avail
influenza
neuraminidas
inhibitor
proven
clinic
efficaci
reduc
sever
symptom
influenza
infect
contrast
antivir
approach
target
hrv
still
develop
yet
appli
viral
exacerb
asthma
copd
assumpt
overexuber
host
inflammatori
respons
viral
infect
play
key
role
diseas
exacerb
valid
sever
potenti
therapeut
approach
suggest
first
would
identifi
specif
viral
signal
pathway
would
target
intervent
could
includ
exampl
specif
earli
signal
pathway
involv
spleen
tyrosin
kinas
syk
pathway
trigger
viral
interact
intracellular
rna
helicas
although
target
specif
chemokin
chemokin
receptor
might
also
prove
attract
target
remain
determin
chemokinechemokinereceptor
system
particularli
import
diseas
pathogenesi
final
enhanc
endogen
host
antivir
pathway
topic
administr
drug
nitric
oxid
donor
could
provid
altern
approach
reduc
viral
induc
inflamm
urgent
need
addit
therapeut
approach
combat
viral
exacerb
asthma
copd
although
past
year
seen
signific
increas
understand
virus
caus
exacerb
much
remain
learn
complex
signal
pathway
trigger
upon
viral
infect
complet
understood
delin
could
provid
novel
therapeut
target
addit
better
understand
host
innat
antivir
mechan
could
provid
altern
therapeut
approach
pathway
stimul
